JAGX Jaguar Health, Inc.
Price Chart
Executive Summary
Jaguar Health issued 54,222 common shares to Streeterville Capital in exchange for the cancellation of 7.96 shares of Series Q Perpetual Preferred Stock, converting preferred equity into common stock without new cash proceeds. Separately, the company adjourned its 2026 Annual Meeting until June 2, 2026, after Nasdaq discussions prompted a supplemental proxy filing, signaling potential governance or compliance concerns.
Actionable Insight
The preferred-to-common conversion without new capital is a bearish signal of financial distress, as it dilutes existing common holders while providing no operating cash. The adjourned annual meeting with Nasdaq discussions raises the risk of a listing deficiency or delisting. Monitor the supplemental proxy filing and any Nasdaq compliance update.
Key Facts
- Issued 54,222 common shares to Streeterville Capital in exchange for 7.96 Series Q Preferred shares (cancelled and retired).
- No new cash raised — the exchange is a debt-to-equity conversion under Section 3(a)(9).
- Annual Meeting adjourned from May 22 to June 2, 2026, due to Nasdaq discussions requiring supplemental proxy information.
- Market cap is ~$49M; the 54,222 common shares represent a material dilution event relative to outstanding shares.
- Historical performance on JAGX filings shows a 33% win rate at T+20 and average alpha of -25.75%.
Financial Impact
54,222 common shares issued; no cash consideration received. Dilution impact depends on pre-exchange share count, which is not disclosed in the filing.
Risk Factors
- Nasdaq listing compliance risk — adjourned meeting suggests potential deficiency or delisting threat.
- Further dilution from additional Streeterville conversions or other financing arrangements.
- No new cash raised — the exchange does not address the company's liquidity needs.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-237195 |
| Document: d138181dex102.htm | 0001193125-26-237195 |
| Document: d138181dex101.htm | 0001193125-26-237195 |
| Document: 0001193125-26-237195-index-headers.html | 0001193125-26-237195 |
| Document: 0001193125-26-237195-index.html | 0001193125-26-237195 |
| Document: 0001193125-26-237195.txt | 0001193125-26-237195 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
8-K
| $2.74 awaiting T+1 | awaiting T+1 | — | $2.69 (+1.82%) |
|
Jun 8, 2026
6d ago
|
8-K
| $2.60 awaiting T+1 | awaiting T+1 | — | $2.69 (+3.66%) |
|
Jun 2, 2026
12d ago
|
8-K
| $2.92 $3.05 | ▼ −4.45% | ▼ −4.05% | $2.69 (+7.88%) |
|
May 29, 2026
16d ago
|
DEFA14A
| $3.27 $3.22 | ▼ −1.53% | ▼ −1.67% | $2.69 (−17.74%) |
|
May 27, 2026
18d ago
|
8-K
| $3.19 $3.29 | ▲ +3.13% | ▲ +2.58% | $2.69 (−15.67%) |
|
May 22, 2026
23d ago
|
8-K
| $3.11 $3.19 | ▼ −2.57% | ▼ −2.56% | $2.69 (+13.50%) |
|
May 19, 2026
26d ago
|
8-K
| $3.67 $3.47 | ▼ −5.45% | ▼ −5.64% | $2.69 (−26.70%) |
|
May 6, 2026
5w ago
|
DEFA14A
| $2.82 $2.98 | ▲ +5.67% | ▲ +6.00% | $2.69 (−4.61%) |
|
May 4, 2026
5w ago
|
8-K
| $3.25 $3.01 | ▲ +7.38% | ▲ +8.18% | $2.69 (+17.23%) |
|
Apr 27, 2026
6w ago
|
8-K
| $9.80 $0.2410 | ▲ +97.54% | ▲ +97.06% | $2.69 (+72.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access